September 16, 2014
Pulmologix raises € 9.6 million to develop a new oral non-steroidal anti-asthmatic drug
Media
September 16, 2014
Nordic Nanovector AS: Final result of the subsequent offering
September 15, 2014
Ultragenyx Announces Positive Results From a Long-Term Phase 1/2 Study of KRN23 in Adult Patients With X-Linked Hypophosphatemia
September 09, 2014
Pulmonx’s Zephyr Endobronchial Valve Demonstrates Statistically and Clinically Significant Results in a Prospective, Randomized Controlled Trial
September 03, 2014
Cerenis receives EMA Orphan Drug Designation for CER-001 for the treatment of APoA-I and ABCA-1 deficiencies
September 03, 2014
Ultragenyx Announces Positive Interim Data From Phase 1/2 Study of Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis 7
September 01, 2014
MIPS + BRG SPORTS
August 29, 2014
Orexo has successfully completed its private placement of approx. SEK 346.5m
August 29, 2014
Onxeo strengthens Beleodaq™ patent protection in the U.S. until 2027
August 29, 2014
Nordic Nanovector – Approved prospectus